MedTrace Logo

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

NCT01538940 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 415

Last updated 2024-09-19

No results posted yet for this study

Summary

This study will assess the efficacy of a new intradermal formulation of the trivalent inactivated influenza vaccine compared to the standard intramuscular vaccine in HIV-infected men who have sex with men in Bangkok, Thailand. Relative efficacy of the two different formulations of influenza vaccine will be assessed by comparing immunologic responses to vaccine between the two study arms.

Conditions

Interventions

BIOLOGICAL

Intradermal vaccine

15ug

BIOLOGICAL

Intramuscular vaccine

15ug

Sponsors & Collaborators

Principal Investigators

  • Charung Muangchana, MD · Ministry of Health, Thailand

  • Prasert Thongcharoen, MD · Influenza Foundation of Thailand

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-01
Primary Completion
2013-09-09
Completion
2015-10-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538940 on ClinicalTrials.gov